Actively Recruiting
Reducing Fatigue in People With Multiple Sclerosis by Treatment With TENS
Led by University of Colorado, Boulder · Updated on 2024-12-09
60
Participants Needed
1
Research Sites
292 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of the randomized, sham-controlled trial will be to evaluate the effectiveness of treatment with transcutaneous electrical nerve stimulation (TENS) at reducing the level of fatigue experienced by people with MS.
CONDITIONS
Official Title
Reducing Fatigue in People With Multiple Sclerosis by Treatment With TENS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men and women 18-65 years old
- Able to read, understand, and speak English to ensure safe participation
- Clinical diagnosis of relapsing-remitting multiple sclerosis
- Self-reported difficulty with walking
- On stable doses of Ampyra, provigil, or other symptom-treating medications
- No relapse or systemic steroids within the last 30 days
- Able to arrange transportation to the Boulder campus
You will not qualify if you...
- Vision or hearing problems that have not been corrected
- Problems with sensations to temperature, pressure, or pain
- Any arm or leg problems that affect ability to hold a weight
- Surgery to the arms or legs that continues to bother the participant
- Metal implants
- Medical conditions contraindicating exercise training such as major renal, pulmonary, hepatic, cardiac, gastrointestinal, HIV, cancer (except treated basal cell), other neurological disorders, or pregnancy
- History of head injury or stroke
- Taking antidepressants, anticholinergics, stimulants, sedatives, cannabis, illicit drugs, or medications for herpes or neurologic pain
- Diagnosis of diabetes mellitus
- Poorly controlled hypertension
- History of seizure disorders
- Drinking 2 or more alcoholic drinks per day or recent drug abuse (last 6 months)
- Spasticity requiring activity changes more than once a week
- Skin diseases or sensation problems in legs or hands impacting activities more than once a week
- Unable to attend exercise sessions 3 days per week for 6 weeks
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Colorado
Boulder, Colorado, United States, 80309
Actively Recruiting
Research Team
R
Roger Enoka, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here